210 related articles for article (PubMed ID: 21555517)
1. SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas.
Mitra N; Banda K; Altheide TK; Schaffer L; Johnson-Pais TL; Beuten J; Leach RJ; Angata T; Varki N; Varki A
J Biol Chem; 2011 Jul; 286(26):23003-11. PubMed ID: 21555517
[TBL] [Abstract][Full Text] [Related]
2. Human-specific polymorphic pseudogenization of
Siddiqui SS; Vaill M; Do R; Khan N; Verhagen AL; Zhang W; Lenz HJ; Johnson-Pais TL; Leach RJ; Fraser G; Wang C; Feng GS; Varki N; Varki A
FASEB Bioadv; 2021 Feb; 3(2):69-82. PubMed ID: 33615152
[TBL] [Abstract][Full Text] [Related]
3. Analysis of
Ogbodo AK; Mustafov D; Arora M; Lambrou GI; Braoudaki M; Siddiqui SS
Heliyon; 2024 Jan; 10(2):e24286. PubMed ID: 38268823
[TBL] [Abstract][Full Text] [Related]
4. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.
Läubli H; Alisson-Silva F; Stanczak MA; Siddiqui SS; Deng L; Verhagen A; Varki N; Varki A
J Biol Chem; 2014 Nov; 289(48):33481-91. PubMed ID: 25320078
[TBL] [Abstract][Full Text] [Related]
5. Siglec genes confer resistance to systemic lupus erythematosus in humans and mice.
Flores R; Zhang P; Wu W; Wang X; Ye P; Zheng P; Liu Y
Cell Mol Immunol; 2019 Feb; 16(2):154-164. PubMed ID: 29503442
[TBL] [Abstract][Full Text] [Related]
6. Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology.
Wang X; Chow R; Deng L; Anderson D; Weidner N; Godwin AK; Bewtra C; Zlotnik A; Bui J; Varki A; Varki N
Glycobiology; 2011 Aug; 21(8):1038-48. PubMed ID: 21467073
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
9. A second uniquely human mutation affecting sialic acid biology.
Angata T; Varki NM; Varki A
J Biol Chem; 2001 Oct; 276(43):40282-7. PubMed ID: 11546777
[TBL] [Abstract][Full Text] [Related]
10. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
[TBL] [Abstract][Full Text] [Related]
11. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
[TBL] [Abstract][Full Text] [Related]
12. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.
Su ZZ; Lin J; Shen R; Fisher PE; Goldstein NI; Fisher PB
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7252-7. PubMed ID: 8692978
[TBL] [Abstract][Full Text] [Related]
13. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
Nguyen DH; Ball ED; Varki A
Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
[TBL] [Abstract][Full Text] [Related]
14. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
15. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
16. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
[TBL] [Abstract][Full Text] [Related]
17. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
18. STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer.
Wang L; Jin Y; Arnoldussen YJ; Jonson I; Qu S; Maelandsmo GM; Kristian A; Risberg B; Waehre H; Danielsen HE; Saatcioglu F
Cancer Res; 2010 Jul; 70(14):5818-28. PubMed ID: 20587517
[TBL] [Abstract][Full Text] [Related]
19. Specific inactivation of two immunomodulatory SIGLEC genes during human evolution.
Wang X; Mitra N; Secundino I; Banda K; Cruz P; Padler-Karavani V; Verhagen A; Reid C; Lari M; Rizzi E; Balsamo C; Corti G; De Bellis G; Longo L; ; Beggs W; Caramelli D; Tishkoff SA; Hayakawa T; Green ED; Mullikin JC; Nizet V; Bui J; Varki A
Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9935-40. PubMed ID: 22665810
[TBL] [Abstract][Full Text] [Related]
20. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans.
Cao H; Lakner U; de Bono B; Traherne JA; Trowsdale J; Barrow AD
Eur J Immunol; 2008 Aug; 38(8):2303-15. PubMed ID: 18629938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
